Developing viable and profitable new drugs today often requires working with new chemical entities (NCEs) that are poorly water soluble.
Developing viable and profitable new drugs today often requires working with new chemical entities (NCEs) that are poorly water soluble.
Many of today’s NCE's require time-consuming experimentation and analysis in order to achieve satisfactory drug absorption from a solid oral dosage form – a challenge that can sometimes take years of development without yielding positive results. While at the same time, opportunities for unique OTC line extensions and generics abound.
Utilizing lipid-based technology, Capsugel developed proprietary systems designed to help you meet the challenges of formulating or re-formulating drugs in a liquid-filled format. Our approach offers significant benefits in quickly solving some of your most difficult drug development challenges including:
Not only does formulating in liquids help overcome obstacles once thought to be insurmountable, but it also can reduce development time. Time saved = more time selling under patent protection = increased revenue.
From initial discovery to full-scale commercial production, Capsugel has the global resources, knowledge, and talent to help you exceed your objectives.